Search results
Author(s):
Raffaele De Caterina
,
Giulia Renda
Added:
3 years ago
Limitations of Coumarin Derivatives in Atrial Fibrillation and the Quest for New Drugs
Warfarin and similar coumarin derivatives (vitamin K antagonists [VKAs]) clearly have the greatest efficacy among the currently available treatments (mostly aspirin) in preventing stroke in atrial fibrillation (AF).1 However, they carry a substantial risk of major bleeding (approximately 1.2% per year) and…
View more
Author(s):
Maki Komiyama
,
Gheorghe-Andrei Dan
,
Koji Hasegawa
Added:
11 months ago
Author(s):
Maki Komiyama
,
Koji Hasegawa
Added:
3 years ago
Coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has generated a pandemic that has heavily affected the global population, with more than 5.2 million infected and more than 337,000 deaths worldwide recorded between the end of 2019 and 24 May 2020.1 In the absence of vaccines or specific targeted treatments, strategies to…
View more
Ken Okumura
Author
Author(s):
Ken Okumura
Added:
3 years ago
Dr Ken Okumura (Saiseikai Kumamoto Hospital, Kumamoto, JP) discusses the rationale and results behind ELDERCARE-AF, which investigates low dose Edoxaban for elderly Japanese AF patients ineligible for standard anticoagulant therapy.
Questions:
1. What is the rationale for this study?
2. What were the objectives of this study, and its design?
3. What patients were included in the study?
4. What…
View more
Author(s):
Maria Cristina Beznă
,
Suzana Dănoiu
,
Marinela Beznă
,
et al
Added:
11 months ago
Author(s):
Pierluigi Merella
,
Giuseppe Talanas
,
Giovanni Lorenzoni
,
et al
Added:
6 months ago
Author(s):
Yugo Yamashita
Added:
7 months ago
ESC 23 — In this concise interview, Dr Yugo Yamashita (Kyoto University Graduate School of Medicine, JP) reveals the findings of the ONCO DVT Study (NCT03895502).
The ONCO DVT study (Takeshi Morimoto) aimed to determine the ideal duration of anticoagulation therapy with the direct oral anticoagulant (DOAC) edoxaban for the treatment of isolated distal deep vein thrombosis (IDDVT) in patients…
View more
Implantable Cardiac Monitors for the Detection of Atrial Fibrillation - How Far Have We Come?
Author(s):
Christian Meyer
,
Martin Martinek
,
Helmut Pürerfellner
Added:
3 years ago
Article